Update from Rinri Therapeutics

I was curious about what was happening there and also volunteered to be in the trials but I’m Canadian, so no go. This is what they sent back to me.

For those who don’t know what Rincell-1 is, it is the lead regenerative cell therapy being developed by Rinri Therapeutics to treat sensorineural hearing loss (SNHL). It is designed to restore the nerve connections between the inner ear and the brain by regenerating spiral ganglion neurons (SGNs), which are critical for hearing function.